|
FIRST STRAND cDNA SYNTHESIS KIT (M-MULV ) |
|
Kit Contents: |
Components |
SD027, 10 reactions
|
SD028, 20 reactions
|
10 x Reaction Buffer
|
50 µl
|
100 µl
|
25 mM MgCl2
|
500 µl
|
500 µl
|
dNTP Mix,10mM each
|
25 µl
|
50 µl
|
0.05% [w/v] Gelatin
|
50 µl
|
100 µl
|
Oligo-p(dT)15 Primer,
0.8µg/µl
|
15 µl
|
30 µl
|
Random Primer p(dN)6,
2µg/µl
|
15 µl
|
30 µl
|
RNase Inhibitor, 50 U/µl
|
15 µl
|
30 µl
|
MMLV Reverse Transcriptase
|
240 U
|
480 U
|
RNase-free ddH2O
|
1.5 ml
|
1.5 ml
|
Protocol
|
1
|
1
|
Price |
Euro 59
|
Euro 95
|
- It is recommended that
the first strand cDNA synthesis is carried out under conditions
where RNase contamination has been eliminated. Pipette tips and
tubes should be treated with 0.1% diethylpyrocarbonate (DEPC) (soak
overnight in 0.1% aqueous solution of DEPC at 37°C, then heat at
10°C for 30 min and autoclave).
- Wearing gloves is
highly recommended.
- One unit of M-MuLV RT
incorporates 1nmole of deoxyribonucleotide into DE81 absorbable form
in 10min at 37°C.
- One unit of
ribonuclease inhibitor is defined as the amount of protein required
to inhibit 50% of the activity of 5ng of RNase A.
|
Description:
This kit is designed for preparation of full-length first strand cDNA
from RNA templates. The first strand cDNA synthesis kit relies on a
cloned enzyme, Moloney murine leukemia virus reverse transcriptase
(M-MuLV RT). M-MuLV RT synthesizes first strand cDNA at sites determined
by the type of primer used:
- random hexamer primer:
at non-specific points along an RNA template. In this case, all RNA
in a population are templates for cDNA synthesis.
- oligo(dT)18: at the
3´-end of poly(A)+ mRNA. In this case, only mRNA with 3´-poly(A)
tails are templates for cDNA synthesis.
First strand cDNA
synthesized with this system can be used as a template in the polymerase
chain reaction (PCR*). As the reaction conditions of cDNA synthesis and
PCR* are compatible, cDNA reaction mixture can be added directly to a
PCR* mixture. The kit is optimized for maximum yield of full length
cDNA. The addition of ribonuclease inhibitor lowers the risk of mRNA
degradation during the reaction.
The first strand cDNA synthesized may also be used as a template for
second strand synthesis.
*The
Polynucleotide Chain reaction (PCR) is covered by the patents owned by
Hoffman-La Roche Inc.
|
References:
- Sambrook, J.,
Fritsch, E.F. and Maniatis, T., Molecular Cloning: A Laboratory
Manual (2nd Ed.) Cold Spring Harbor University Press, Cold spring
Harbor, NY, 1989.
- Ausubel, F.M.
et al. eds., Current Protocols in Molecular Biology, John Wiley &
Sons, Inc., NY, 1997.
- Gerard, G.F.,
Dlessio, J.M., Meth. in Mol. Biol., V. 16, 73-93, 1993.
|
|
send mail to [email protected] with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified:
05/19/16
|